Mark Ibberson
Impact in
- Cancer Research top 2%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
-
- Diabetes Treatment and Management
Papers in
-
- Congenital heart defects research 4
- Surgery 19
- Pancreatic function and diabetes 18
- Co-authors
- Bernard Thorens (18 shared papers)Marc Uldry (3 shared papers)Frédéric Burdet (10 shared papers)Ioannis Xénarios (18 shared papers)Masaya Hosokawa (1 shared paper)Mario Leonardo Squadrito (1 shared paper)Gregor D. Gilfillan (1 shared paper)Michele De Palma (1 shared paper)
- Journals
- Molecular Metabolism (6 papers)Diabetologia (5 papers)Cell Reports (5 papers)PLoS ONE (3 papers)Journal of Clinical Investigation (3 papers)
- Partner nations
- SwitzerlandUnited KingdomUnited States
In The Last Decade
Mark Ibberson
67 papers receiving 3.6k citations
Mark Ibberson's Hit Papers
Peers
Comparison fields: 5 of 120
- Cancer Research 760
- Endocrinology, Diabetes and Metabolism 481
- Molecular Biology 1.9k
- Endocrine and Autonomic Systems 138
- Surgery 708
Countries citing papers authored by Mark Ibberson
This map shows the geographic impact of Mark Ibberson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Ibberson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Ibberson more than expected).
Fields of papers citing papers by Mark Ibberson
This network shows the impact of papers produced by Mark Ibberson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Ibberson. The network helps show where Mark Ibberson may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Ibberson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 68 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Endogenous RNAs Modulate MicroRNA Sorting to Exosomes and Transfer to Acceptor Cells Hit paper breakdown → | 2014 | 507 |
| 2 | The mitophagy activator urolithin A is safe and induces a molecular signature of improved mitochondrial and cellular health in humans Hit paper breakdown → | 2019 | 427 |
| 3 | 2002 | 272 | |
| 4 | 2014 | 222 | |
| 5 | 2000 | 210 | |
| 6 | 2004 | 198 | |
| 7 | 2004 | 197 | |
| 8 | 2014 | 182 | |
| 9 | 2017 | 176 | |
| 10 | 2020 | 109 | |
| 11 | 2002 | 69 | |
| 12 | 2010 | 58 | |
| 13 | 2017 | 54 | |
| 14 | 2020 | 51 | |
| 15 | 2017 | 51 | |
| 16 | 2018 | 49 | |
| 17 | 2015 | 48 | |
| 18 | 2011 | 46 | |
| 19 | 2016 | 43 | |
| 20 | 2016 | 43 |
About Mark Ibberson
Mark Ibberson is a scholar working on Molecular Biology, Surgery, Immunology, Endocrinology, Diabetes and Metabolism and Physiology, having authored 68 papers that have together received 3.6k indexed citations. Recurring topics across this work include Pancreatic function and diabetes (18 papers), Diabetes Management and Research (5 papers), T-cell and B-cell Immunology (5 papers), Congenital heart defects research (4 papers), Immune Cell Function and Interaction (4 papers), Diabetes and associated disorders (3 papers), Adipose Tissue and Metabolism (3 papers) and Cytokine Signaling Pathways and Interactions (3 papers). The work is most often cited by research in Cancer Research (760 citations), Endocrinology, Diabetes and Metabolism (481 citations), Molecular Biology (1.9k citations), Endocrine and Autonomic Systems (138 citations) and Surgery (708 citations). Mark Ibberson has collaborated with scholars based in Switzerland, United Kingdom and United States. Frequent co-authors include Bernard Thorens, Marc Uldry, Frédéric Burdet, Ioannis Xénarios, Masaya Hosokawa, Mario Leonardo Squadrito, Gregor D. Gilfillan, Michele De Palma, Claudio Maderna and Robert Lyle. Their work appears in journals such as Molecular Metabolism, Diabetologia, Cell Reports, PLoS ONE and Journal of Clinical Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.